InvestorsHub Logo
Followers 900
Posts 148899
Boards Moderated 0
Alias Born 08/13/2010

Re: LionsPride post# 2140

Monday, 10/10/2016 9:04:55 PM

Monday, October 10, 2016 9:04:55 PM

Post# of 2356
$AMRS & Johnson & Johnson $JNJ via Janssen. Recently entered into research agreement with commercial license option with Janssen Biotech, facilitated by Johnson & Johnson Innovation, to use Amyris’s µPharm platform for rapid integrated discovery and production of therapeutic compounds thereby opening a new area of compounds previously not accessible for new drug discovery. “We expect to sign one more collaboration by the end of the year, ending at the high-end of our range, to develop a library of natural and natural like of therapeutic compounds, which nature has the potential to provide and we have the ability to produce.”
http://www.biofuelsdigest.com/bdigest/2016/08/14/amyris-the-new-colossus-aims-to-unlock-its-golden-door/

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.